Kerem Ben‐Meir

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index520citations50works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gut microbiota and health(35), Immune cells in cancer(7), Cancer Research and Treatments(4), Gastrointestinal motility and disorders(3), Immune Response and Inflammation(3)

Publications50 total

Pro-Inflammatory Macrophage Phenotype Skewing Induced by Tumor Treating Fields (TTFields)
International Journal of Molecular Sciences·2025Open Access
Correction: Functional Assays Evaluating Immunosuppression Mediated by Myeloid‐Derived Suppressor Cells
Current Protocols·2024Open Access
Preclinical Efficacy of TTFields and PARP Inhibitors in Ovarian Cancer Models
International Journal of Radiation Oncology*Biology*Physics·2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance
Frontiers in Oncology·2024· 7 citedOpen Access
Figure S5 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S6 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
FIGURE 3 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S4 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
FIGURE 2 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S7 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S2 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S7 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
FIGURE 8 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S4 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S3 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
FIGURE 1 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
FIGURE 2 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S8 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
Figure S8 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
FIGURE 3 from The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Michal Baniyash(42), Nira Twaik(41), Yaron Meirow(40), Hadas Ashkenazi‐Preiser(39), Ivan Mikula(39), Or Reuven(39), Leonor Cohen‐Daniel(37), Atara Uzan-Yulzari(35), Sharon Komisarov(35), Roy Cirkin(35), Sondra Turjeman(35), Carmel Even(35), Eli Pikarsky(35), Yoram Louzoun(35), Omry Koren(35), Yoram Palti(6), Moshe Giladi(5), Guy Kariv(4), Leonor Daniel(4), Hila Ene(4)